Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOW (Unaudited)

v3.19.3.a.u2
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOW (Unaudited) - USD ($)
3 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Statement of Cash Flows [Abstract]    
Net Loss $ (37,184) $ (111,160)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of ReadyOp software platform 10,878 16,299
Amortization of ReadyOp customer list 8,046
Amortization of ReadyMed software platform 38,356
Provision for bad debt (13,335) 8,000
(Increase) decrease in assets:    
Accounts receivable 56,391 39,295
Inventory (69,213) (23,010)
Prepaid expenses and other current assets 23,656 (18,000)
Assets from discontinued operations 9,234 (38,445)
Increase (decrease) in liabilities:    
Accounts payable 35,946 (50,688)
Accrued expenses 15,317 42,622
Deferred revenue (161,184) 18,835
Customer deposit 2,000
Liabilities from discontinued operations (11,575) 60,582
Net Cash Used in Operating Activities (102,713) (45,624)
Cash Flows From Investing Activities    
Issuance of note receivable - discontinued operations (25,000)
Net Cash Used in Investing Activities (25,000)
Cash Flows From Financing Activities    
Proceeds from issuance of installment loan-discontinued operations 43,600 43,810
Repayment of installment loan - discontinued operations (30,277) (1,940)
Proceeds from notes payable 50,000
Repayment of notes payable stockholders (5,826)
Proceeds from loan payable - related party 9,000
Proceeds from loan payable - related party - discontinued operations 7,262
Proceeds from issuance of Common Stock 75,000
Cash overdraft 1,580
Net Cash Provided by Financing Activities 75,339 116,870
Net Increase (Decrease) In Cash (27,374) 46,246
Cash at beginning of period 27,698 413
Cash at end of period 324 46,659
SUPPLEMENTAL CASH FLOW INFORMATION:    
Cash paid for interest 1,742
Cash paid for taxes
Supplemental disclosure of non-cash investing and financing activities:    
Operating lease asset obtained for operating lease liability from discontinued operations 75,078
Common stock issued for ReadyMed Platform $ 600,000